Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4639) 4639
Book Review (1440) 1440
Book / eBook (650) 650
Publication (374) 374
Book Chapter (33) 33
Conference Proceeding (19) 19
Dissertation (3) 3
Magazine Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4369) 4369
index medicus (4369) 4369
female (2931) 2931
oncology (2166) 2166
cancer (1902) 1902
middle aged (1649) 1649
male (1602) 1602
breast cancer (1459) 1459
aged (1324) 1324
adult (1251) 1251
risk factors (807) 807
animals (801) 801
tumors (792) 792
research (777) 777
prostate cancer (740) 740
prognosis (722) 722
breast neoplasms - pathology (700) 700
health aspects (629) 629
care and treatment (594) 594
medicine & public health (588) 588
breast neoplasms - drug therapy (574) 574
estrogen (543) 543
aged, 80 and over (533) 533
carcinoma (502) 502
diagnosis (498) 498
neoplasms (497) 497
breast neoplasms - metabolism (494) 494
expression (483) 483
neoplasms, hormone-dependent - drug therapy (449) 449
postmenopausal women (447) 447
breast-cancer (437) 437
risk (431) 431
breast neoplasms - genetics (430) 430
chemotherapy (430) 430
therapy (429) 429
analysis (417) 417
prostatic neoplasms - pathology (416) 416
metastasis (412) 412
genetic aspects (408) 408
antineoplastic agents, hormonal - therapeutic use (404) 404
women (399) 399
medicine (395) 395
development and progression (379) 379
immunohistochemistry (375) 375
neoplasms, hormone-dependent - pathology (375) 375
treatment outcome (366) 366
cell line, tumor (361) 361
abridged index medicus (345) 345
gene expression (342) 342
pathology (335) 335
prostatic neoplasms - drug therapy (333) 333
tamoxifen (331) 331
neoplasm staging (328) 328
mice (318) 318
endocrinology & metabolism (316) 316
gene expression regulation, neoplastic (313) 313
case-control studies (307) 307
survival (302) 302
research article (297) 297
breast neoplasms - epidemiology (289) 289
obstetrics & gynecology (289) 289
epidemiology (286) 286
surgery (279) 279
oncology, experimental (278) 278
biochemistry & molecular biology (274) 274
breast (273) 273
apoptosis (271) 271
receptors, estrogen - metabolism (263) 263
urology & nephrology (263) 263
hormones (262) 262
cancer research (260) 260
drug therapy (256) 256
cells (248) 248
retrospective studies (247) 247
prostatic neoplasms - metabolism (236) 236
neoplasm metastasis (234) 234
breast neoplasms - diagnosis (233) 233
cell biology (233) 233
article (230) 230
menopause (230) 230
prostatic neoplasms - genetics (230) 230
antineoplastic agents - therapeutic use (228) 228
physiological aspects (228) 228
growth (222) 222
neoplasms, hormone-dependent - metabolism (222) 222
disease progression (221) 221
estrogens (221) 221
breast neoplasms - mortality (218) 218
gene-expression (215) 215
receptors, estrogen - analysis (215) 215
proteins (212) 212
tamoxifen - therapeutic use (211) 211
incidence (208) 208
signal transduction (204) 204
mortality (203) 203
androgens (202) 202
follow-up studies (202) 202
endometrial cancer (198) 198
estrogen-receptor (197) 197
postmenopause (197) 197
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (541) 541
Collection Dvlpm't (Acquisitions) - Closed Orders (38) 38
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (17) 17
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Online Resources - Online (11) 11
Humber River Regional Hospital - Finch Stacks (9) 9
Scarborough Hospital - Birchmount (7) 7
Scarborough Hospital - General (7) 7
St. Michael's Hospital - Stacks (7) 7
Humber River Regional Hospital - Church Stacks (6) 6
Markham Stouffville Hospital - Stacks (6) 6
Lakeridge Health Sciences - Oshawa (5) 5
UofT at Mississauga - Stacks (5) 5
Mt Sinai Hospital - Pathology (4) 4
Providence Healthcare - Stacks (4) 4
Chemistry (A D Allen) - Stacks (3) 3
Credit Valley Hospital - Stacks (3) 3
Gerstein Science - Circulation Desk (3) 3
Gerstein Science - Reference (2) 2
OISE - Stacks (2) 2
St Josephs Health Centre - Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - Special Collections (1) 1
Gerstein Science - Not Returned (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Markham Stouffville Hospital - Storage (1) 1
New College (Ivey) - Stacks (1) 1
Toronto East General Hospital - Missing (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5163) 5163
German (38) 38
French (34) 34
Spanish (34) 34
Russian (25) 25
Japanese (11) 11
Hungarian (5) 5
Chinese (4) 4
Italian (3) 3
Bulgarian (2) 2
Turkish (2) 2
Arabic (1) 1
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Korean (1) 1
Persian (1) 1
Polish (1) 1
Portuguese (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Neuroendocrine gastro-entero-pancreatic tumors: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
by Öberg, K and Knigge, U and Kwekkeboom, D and Perren, A and ESMO Guidelines Working Grp and ESMO Guidelines Working Group and on behalf of the ESMO Guidelines Working Group and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Institutionen för medicinska vetenskaper and Onkologisk endokrinologi
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue 7, pp. vii124 - vii130
LIVER METASTASES | SURVIVAL | SOMATOSTATIN ANALOGS | HEPATIC-METASTASES | POSITRON-EMISSION-TOMOGRAPHY | MANAGEMENT | PROGNOSTIC-FACTORS | EVEROLIMUS | ONCOLOGY | CHEMOTHERAPY | RADIOFREQUENCY ABLATION | Neoplasms, Hormone-Dependent - diagnosis | Neuroendocrine Tumors - pathology | Stomach Neoplasms - diagnosis | Risk Assessment | Pancreatic Neoplasms - diagnosis | Humans | Pancreatic Neoplasms - pathology | Stomach Neoplasms - therapy | Stomach Neoplasms - pathology | Treatment Outcome | Combined Modality Therapy | Neuroendocrine Tumors - diagnosis | Intestinal Neoplasms - pathology | Randomized Controlled Trials as Topic | Intestinal Neoplasms - therapy | Neoplasms, Hormone-Dependent - therapy | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Neuroendocrine Tumors - therapy | Intestinal Neoplasms - diagnosis | Neoplasm Staging | Pancreatic Neoplasms - therapy | Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
by Berruti, A and Baudin, E and Gelderblom, H and Haak, H.R and Porpiglia, F and Fassnacht, M and Pentheroudakis, G and ESMO Guidelines Working Grp and ESMO Guidelines Working Group and on behalf of the ESMO Guidelines Working Group
Annals of Oncology, ISSN 0923-7534, 10/2012, Volume 23, Issue 7, pp. vii131 - vii138
MITOTANE | MANAGEMENT | PHEOCHROMOCYTOMA | ONCOLOGY | RECOMMENDATIONS | PREDICTORS | ADRENOCORTICAL CARCINOMA | PHASE-II | CLASSIFICATION | PROGNOSTIC VALUE | EXPRESSION | Neoplasms, Hormone-Dependent - diagnosis | Risk Assessment | Pheochromocytoma - diagnosis | Adrenocortical Carcinoma - secondary | Humans | Adrenocortical Carcinoma - diagnosis | Chemoradiotherapy, Adjuvant | Adrenocortical Carcinoma - therapy | Mitotane - therapeutic use | Adrenal Gland Neoplasms - diagnosis | Adrenalectomy | Neoplasms, Hormone-Dependent - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Pheochromocytoma - secondary | Neoplasm Staging | Pheochromocytoma - therapy | Adrenal Gland Neoplasms - pathology | Adrenal Gland Neoplasms - therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
by Cardoso, F and Senkus-Konefka, E and Fallowfield, L and Costa, A and Castiglione, M and ESMO Guidelines Working Grp and ESMO Guidelines Working Group and On behalf of the ESMO Guidelines Working Group
Annals of Oncology, ISSN 0923-7534, 05/2010, Volume 21, Issue 5, pp. v15 - v19
TRIAL | CAPECITABINE | SURVIVAL | TRASTUZUMAB | ONCOLOGY | RECOMMENDATIONS | COMBINATION | DOCETAXEL | CHEMOTHERAPY | PLUS | PACLITAXEL | Neoplasms, Hormone-Dependent - diagnosis | Neoplasm Metastasis - therapy | Premenopause | Humans | Neoplasm Recurrence, Local - therapy | Europe - epidemiology | Treatment Outcome | Antineoplastic Agents - therapeutic use | Neoplasm Recurrence, Local - diagnosis | Breast Neoplasms - therapy | Neoplasms, Hormone-Dependent - therapy | Breast Neoplasms - pathology | Neoplasm Metastasis - diagnosis | Postmenopause | Female | Breast Neoplasms - diagnosis | Neoplasm Staging | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Analytical Validation of the Oncotype DX Genomic Diagnostic Test for Recurrence Prognosis and Therapeutic Response Prediction in Node-Negative, Estrogen Receptor-Positive Breast Cancer
by Cronin, Maureen and Sangli, Chithra and Liu, Mei-Lan and Pho, Mylan and Dutta, Debjani and Nguyen, Anhthu and Jeong, Jennie and Wu, Jenny and Langone, Kim Clark and Watson, Drew
Clinical Chemistry, ISSN 0009-9147, 06/2007, Volume 53, Issue 6, pp. 1084 - 1091
Background: Oncotype DXTM is a clinically validated, high-complexity, multianalyte reverse transcription-PCR genomic test that predicts the likelihood of... 
VARIABILITY | TUMOR GENE-EXPRESSION | ASSAY | ONCOLOGY | MARKER | QUANTIFICATION | CLASSIFICATION | MODEL | MEDICAL LABORATORY TECHNOLOGY | SIGNATURE | CLASSIFIERS | Neoplasms, Hormone-Dependent - diagnosis | Neoplasms, Hormone-Dependent - metabolism | Receptors, Estrogen - metabolism | Reproducibility of Results | Prognosis | Biomarkers, Tumor - analysis | Humans | Neoplasm Recurrence, Local - diagnosis | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Likelihood Functions | Reference Standards | Breast Neoplasms - genetics | Female | Molecular Diagnostic Techniques - standards | Breast Neoplasms - diagnosis | Gene Expression Profiling - standards | Genome, Human | Care and treatment | Cancer | Diagnostic tests | Breast cancer | Patients | Mass spectrometry | Clinical outcomes | Methods | Deoxyribonucleic acid--DNA | Validation studies | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Prognostic utility of HOXB13 : IL17BR and molecular grade index in early-stage breast cancer patients from the Stockholm trial
by Jerevall, P.-L and Ma, X.-J and Li, H and Salunga, R and Kesty, N.C and Erlander, M.G and Sgroi, D.C and Holmlund, B and Skoog, L and Fornander, T and Nordenskjöld, B and Stål, O and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologiska kliniken US and Centrum för kirurgi, ortopedi och cancervård and Östergötlands Läns Landsting and Onkologi and Hälsouniversitetet and Kirurgi- och onkologicentrum
British Journal of Cancer, ISSN 0007-0920, 05/2011, Volume 104, Issue 11, pp. 1762 - 1769
BACKGROUND: A dichotomous index combining two gene expression assays, HOXB13:IL17BR (H : I) and molecular grade index (MGI), was developed to assess risk of... 
recurrence | risk assessment | gene expression profiling | prognosis | Breast Cancer Index | 2-GENE EXPRESSION RATIO | SURVIVAL | ASSAY | RECEPTOR | PREDICTION | WOMEN | THERAPY | ONCOLOGY | ADJUVANT TAMOXIFEN | Neoplasms, Hormone-Dependent - diagnosis | Prognosis | Risk Assessment | Biomarkers, Tumor - analysis | Early Detection of Cancer | Humans | Receptors, Interleukin - analysis | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Neoplasm Metastasis | Sweden | Breast Neoplasms - pathology | Homeodomain Proteins - analysis | Tamoxifen - therapeutic use | Postmenopause | Breast Neoplasms - mortality | Female | Breast Neoplasms - diagnosis | Index Medicus | Molecular Diagnostics | Medical and Health Sciences | Medicin och hälsovetenskap | MEDICIN | MEDICINE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Is the Ki-67 labelling index ready for clinical use?
by Jonat, W and Arnold, N
Annals of Oncology, ISSN 0923-7534, 03/2011, Volume 22, Issue 3, pp. 500 - 502
POSITIVE BREAST-CANCER | ONCOLOGY | PROGNOSIS | TAMOXIFEN | MARKERS | ENDOCRINE THERAPY | ANTIBODY | CELL-PROLIFERATION | KI67 | CHEMOTHERAPY | ANTIGEN | Neoplasms, Hormone-Dependent - diagnosis | Predictive Value of Tests | Humans | Ki-67 Antigen - metabolism | Treatment Outcome | Breast Neoplasms - drug therapy | Molecular Diagnostic Techniques | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Staining and Labeling | Tamoxifen - therapeutic use | Biomarkers, Tumor - metabolism | Female | Breast Neoplasms - diagnosis | Neoplasms, Hormone-Dependent - drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
by Asad, Juhi and Jacobson, Allyson F and Estabrook, Alison and Smith, Sharon Rosenbaum and Boolbol, Susan K and Feldman, Sheldon M and Osborne, Michael P and Boachie-Adjei, Kwadwo and Twardzik, Wendy and Tartter, Paul I
American Journal of Surgery, ISSN 0002-9610, 10/2008, Volume 196, Issue 4, pp. 527 - 529
Background: Oncotype DX is a 21-gene assay that calculates a risk of distant recurrence in women with estrogen-receptor-positive, lymph node-negative breast... 
Assay | Breast cancer | Management | 21-gene | Recurrence score | SURGERY | Neoplasms, Hormone-Dependent - metabolism | Molecular Diagnostic Techniques - methods | Receptors, Estrogen - metabolism | Prognosis | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Breast Neoplasms - metabolism | Neoplasms, Hormone-Dependent - genetics | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Decision Making | Neoplasms, Hormone-Dependent - diagnosis | Reproducibility of Results | Risk Assessment | Biomarkers, Tumor - analysis | Gene Expression Profiling - methods | Neoplasm Recurrence, Local - diagnosis | Breast Neoplasms - drug therapy | Breast Neoplasms - genetics | Aged | Breast Neoplasms - diagnosis | Neoplasms, Hormone-Dependent - drug therapy | Neoplasm Staging | Care and treatment | Cancer patients | Diagnosis | Studies | Chemotherapy | Histology | Patients | Cancer therapies | Age | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Pancreatic well-differentiated neuroendocrine neoplasms (PWDNENS): What place for everolimus and sunitinib derived from esmo clinical practice guidelines in the therapeutic algorithm?
by Pusceddu, S and Buzzoni, R and De braud, F
Annals of Oncology, ISSN 0923-7534, 05/2013, Volume 24, Issue 5, pp. 1415 - 1416
ONCOLOGY | TUMORS | Neoplasms, Hormone-Dependent - diagnosis | Neuroendocrine Tumors - diagnosis | Stomach Neoplasms - diagnosis | Intestinal Neoplasms - diagnosis | Pancreatic Neoplasms - diagnosis | Humans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes
by Smid, Marcel and Hoes, Marlous and Sieuwerts, Anieta M and Sleijfer, Stefan and Zhang, Yi and Wang, Yixin and Foekens, John A and Martens, John W. M
Breast Cancer Research and Treatment, ISSN 0167-6806, 7/2011, Volume 128, Issue 1, pp. 23 - 30
One of the hallmarks of human solid tumors is chromosomal instability (CIN). We studied global patterns as well as individual levels of CIN and determined the... 
Oncology | Subtypes | Prognosis | Chromosomal instability | Medicine & Public Health | SNP copy number | ARRAY | METASTASIS | GENE-EXPRESSION PROFILES | HYPOXIA | SIGNATURE | TUMORS | ONCOLOGY | MICROARRAYS | COMPARATIVE GENOMIC HYBRIDIZATION | Neoplasms, Hormone-Dependent - metabolism | Neoplasms, Hormone-Dependent - mortality | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Incidence | Neoplasms, Hormone-Dependent - genetics | Receptors, Progesterone - metabolism | Statistics, Nonparametric | Adult | Female | Transcription, Genetic | Chromosomal Instability | Neoplasms, Hormone-Dependent - diagnosis | Receptors, Estrogen - genetics | Genetic Association Studies | Kaplan-Meier Estimate | Gene Dosage | Breast Neoplasms - genetics | Breast Neoplasms - mortality | Aged | Breast Neoplasms - diagnosis | Development and progression | Breast cancer | Genetic aspects | Progesterone | Estrogen | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
by Ogawa, Yoshinari and Hai, Eishu and Matsumoto, Kanako and Ikeda, Katsumi and Tokunaga, Shinya and Nagahara, Hisashi and Sakurai, Katsunobu and Inoue, Takeshi and Nishiguchi, Yukio
International Journal of Clinical Oncology, ISSN 1341-9625, 10/2008, Volume 13, Issue 5, pp. 431 - 435
Breast cancer is a hormone-dependent tumor. Most breast cancer cells have an androgen receptor (AR), but the clinical value of AR expression is unclear.AR... 
Postmenopausal | Pathology | Medicine & Public Health | Diagnostic Radiology | Androgen receptor | Triple-negative | Internal Medicine | Oncology | Breast cancer | Radiotherapy | Surgical Oncology | WOMEN | THERAPY | ONCOLOGY | TESTOSTERONE | MEDROXYPROGESTERONE ACETATE | ENDOCRINE | Immunohistochemistry | Neoplasms, Hormone-Dependent - diagnosis | Neoplasms, Hormone-Dependent - metabolism | Receptors, Estrogen - metabolism | Biomarkers, Tumor - analysis | Humans | Menopause | Receptors, Androgen - metabolism | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - pathology | Female | Breast Neoplasms - diagnosis | Care and treatment | Estrogen | Postmenopausal women | Metastasis | Epidermal growth factor | Analysis | Progesterone | Biological markers | Tumor proteins | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Protocol of the 500th jubilee meeting of the Society of Oncologists, devoted to the theme of "Hormone-dependent tumors -- pathogenesis and therapy," May 12, 2014
by Beliaev, A M and Tsyrlina, E V and Bershteĭn, L M and Semiglazov, V F and Berlev, I V and Mikhnin, A E
Voprosy onkologii, ISSN 0507-3758, 2014, Volume 60, Issue 5, p. 651
Neoplasms, Hormone-Dependent - diagnosis | Humans | Male | Prostatic Neoplasms - diagnosis | Neoplasms, Hormone-Dependent - physiopathology | Prostatic Neoplasms - therapy | Russia | Breast Neoplasms - therapy | Medical Oncology | Neoplasms, Hormone-Dependent - therapy | Societies, Medical | Neoplasms, Hormone-Dependent - pathology | Female | Breast Neoplasms - diagnosis
Journal Article
Details down arrow
12. Full Text Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: Application to measurement of oestrogen and progesterone receptor levels in breast cancer
by Rexhepaj, Elton and Brennan, Donal J and Holloway, Peter and Kay, Elaine W and McCann, Amanda H and Landberg, Goran and Duffy, Michael J and Jirstrom, Karin and Gallagher, William M and Pathology, Malmö and Oncology and Pathology, Kamprad Lab and Lund University and Lunds universitet and Patologi, Malmö and Onkologi och Patologi, Kampradlab
Breast Cancer Research, ISSN 1465-5411, 10/2008, Volume 10, Issue 5, pp. R89 - R89
Introduction Manual interpretation of immunohistochemistry (IHC) is a subjective, time-consuming and variable process, with an inherent intra-observer and... 
TRIAL | AUTOMATED QUANTITATIVE-ANALYSIS | ONCOLOGY | QUANTIFICATION | TAMOXIFEN | LYMPH-NODES | RECURRENCE | TISSUE MICROARRAY | CARCINOMA | TECHNOLOGY | HORMONAL-THERAPY | Image Processing, Computer-Assisted - statistics & numerical data | Immunohistochemistry | Neoplasms, Hormone-Dependent - metabolism | Nuclear Proteins - analysis | Estrogens | Humans | Middle Aged | Receptors, Estrogen - analysis | Breast Neoplasms - metabolism | Carcinoma - chemistry | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Estrogen Receptor Modulators - therapeutic use | Nuclear Proteins - biosynthesis | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Image Processing, Computer-Assisted - instrumentation | Neoplasms, Hormone-Dependent - chemistry | Adult | Female | Carcinoma - drug therapy | Neoplasms, Hormone-Dependent - diagnosis | Neoplasm Proteins - biosynthesis | Treatment Outcome | Image Processing, Computer-Assisted - methods | Breast Neoplasms - drug therapy | Algorithms | Tamoxifen - therapeutic use | Receptors, Estrogen - biosynthesis | Neoplasm Proteins - analysis | Aged | Carcinoma - metabolism | Neoplasms, Hormone-Dependent - drug therapy | Progesterone | Cohort Studies | Receptors, Progesterone - biosynthesis | Care and treatment | Receptors | Usage | Analysis | Estrogen | Breast cancer | Genetic aspects | Diagnosis | Health aspects | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Developing imaging strategies for castration resistant prostate cancer
by Fox, Josef J and Morris, Michael J and Larson, Steven M and Schöder, Heiko and Scher, Howard I
Acta Oncologica, ISSN 0284-186X, 06/2011, Volume 50, Issue S1, pp. 39 - 48
Abstract Recent advances in the understanding of castrate-resistant prostate cancer (CRPC) have lead to a growing number of experimental therapies, many of... 
ANDROGEN RECEPTOR | SURROGATE END-POINTS | POSITRON-EMISSION-TOMOGRAPHY | MEMBRANE ANTIGEN | SOLID TUMORS | ONCOLOGY | BONE-SCINTIGRAPHY | CLINICAL-TRIALS | DRUG DEVELOPMENT | ABIRATERONE ACETATE | ANTITUMOR-ACTIVITY | Neoplasms, Hormone-Dependent - diagnosis | Diagnostic Imaging | Magnetic Resonance Imaging | Prognosis | Castration | Humans | Male | Positron-Emission Tomography | Prostatic Neoplasms - diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Multicenter Randomized Phase II Study of Two Schedules of Docetaxel, Estramustine, and Prednisone Versus Mitoxantrone Plus Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
by Stéphane Oudard and Eugeniu Banu and Philippe Beuzeboc and Eric Voog and Louis Marie Dourthe and Anne Claire Hardy-Bessard and Claude Linassier and Florian Scotté and Adela Banu and Yvan Coscas and François Guinet and Marie-France Poupon and Jean-Marie Andrieu
Journal of Clinical Oncology, ISSN 0732-183X, 05/2005, Volume 23, Issue 15, pp. 3343 - 3351
Purpose Mitoxantrone-corticosteroid is currently the standard palliative treatment in hormone-refractory prostate cancer (HRPC) patients. Recent clinical... 
PROGNOSTIC FACTORS | TRIAL | PHOSPHATE | DEXAMETHASONE | THERAPY | PAIN | ONCOLOGY | CARCINOMA | HYDROCORTISONE | CHEMOTHERAPY | ANTIGEN | Multivariate Analysis | Neoplasms, Hormone-Dependent - mortality | Follow-Up Studies | Mitoxantrone - administration & dosage | Estramustine - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Prostatic Neoplasms - diagnosis | Prostate-Specific Antigen - analysis | Dose-Response Relationship, Drug | Neoplasm Invasiveness - pathology | Aged, 80 and over | Mitoxantrone - adverse effects | Prostatic Neoplasms - drug therapy | Taxoids - adverse effects | Neoplasms, Hormone-Dependent - diagnosis | Prednisone - administration & dosage | Prednisone - adverse effects | Drug Administration Schedule | Biomarkers, Tumor - analysis | Risk Factors | Proportional Hazards Models | Treatment Outcome | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease Progression | Prostatic Neoplasms - mortality | Taxoids - administration & dosage | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasms, Hormone-Dependent - drug therapy | Neoplasm Staging | Estramustine - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Development of cDNA microarray for expression profiling of estrogen-responsive genes
by Inoue, A and Yoshida, N and Omoto, Y and Oguchi, S and Yamori, T and Kiyama, R and Hayashi, S
Journal of Molecular Endocrinology, ISSN 0952-5041, 10/2002, Volume 29, Issue 2, pp. 175 - 192
Estrogen plays an important role in many physiological events including carcinogenesis and the development of human breast cancer. However, the molecular... 
HUMAN-BREAST-CANCER | CELL-LINE MCF-7 | MESSENGER-RNA | REGULATED GENES | DNA-DAMAGE | GROWTH | ENDOCRINOLOGY & METABOLISM | BINDING-PROTEIN | MOLECULAR-CLONING | PROLIFERATION | RECEPTOR-ALPHA | Neoplasms, Hormone-Dependent - diagnosis | Estrogens - physiology | Oligonucleotide Array Sequence Analysis - methods | Humans | Estrogen Antagonists - pharmacology | Gene Expression Profiling - methods | Receptors, Estrogen - analysis | Neoplasms, Hormone-Dependent - genetics | Blotting, Northern | Breast Neoplasms - genetics | Estrogen Receptor alpha | Female | Breast Neoplasms - diagnosis | Tumor Cells, Cultured | Estradiol - pharmacology | Index Medicus
Journal Article
Details down arrow
16. Full Text MAMMARY GLAND ADENOCARCINOMA IN A MALE BORNEAN ORANGUTAN (PONGO PYGMAEUS)
by Carpenter, NA and Crook, EK
JOURNAL OF ZOO AND WILDLIFE MEDICINE, ISSN 1042-7260, 03/2017, Volume 48, Issue 1, pp. 224 - 227
An adult male Bornean orangutan (Pongo pygmaeus) was diagnosed with invasive, poorly differentiated grade 9/9 mammary gland adenocarcinoma from a subcutaneous... 
BRCA | Anastrozole | orangutan | mammary gland adenocarcinoma | VETERINARY SCIENCES | BRCA1 | CANCER | Pongo pygmaeus | tamoxifen | BREAST | Neoplasms, Hormone-Dependent - diagnosis | Neoplasms, Hormone-Dependent - veterinary | Adenocarcinoma - pathology | Mammary Neoplasms, Animal - diagnosis | Ape Diseases - surgery | Ape Diseases - pathology | Male | Ape Diseases - drug therapy | Neoplasms, Hormone-Dependent - therapy | Adenocarcinoma - diagnosis | Adenocarcinoma - veterinary | Mammary Neoplasms, Animal - pathology | Mammary Neoplasms, Animal - surgery | Animals | Adenocarcinoma - therapy | Neoplasms, Hormone-Dependent - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Tamoxifen - therapeutic use | Ape Diseases - diagnosis | Mammary Neoplasms, Animal - drug therapy | Nitriles - therapeutic use | Triazoles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Pigmented Cutaneous Metastasis of Breast Carcinoma Mimicking a Melanoma
by